BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 29431527)

  • 1. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
    Di Cori A; Lilli A; Zucchelli G; Zaca V
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.
    Lau CP; Siu CW; Yiu KH; Lee KL; Chan YH; Tse HF
    Europace; 2015 Oct; 17 Suppl 2():ii40-6. PubMed ID: 26842114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covert atrial fibrillation and atrial high-rate episodes as a potential cause of embolic strokes of undetermined source: Their detection and possible management strategy.
    Tomita H; Sasaki S; Hagii J; Metoki N
    J Cardiol; 2018 Jul; 72(1):1-9. PubMed ID: 29609876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.
    Benezet-Mazuecos J; Rubio JM; Cortés M; Iglesias JA; Calle S; de la Vieja JJ; Quiñones MA; Sanchez-Borque P; de la Cruz E; Espejo A; Farré J
    Europace; 2015 Mar; 17(3):364-9. PubMed ID: 25336664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of atrial high-rate episodes on the risk of future stroke.
    Nakano M; Kondo Y; Nakano M; Kajiyama T; Hayashi T; Ito R; Takahira H; Kobayashi Y
    J Cardiol; 2019 Aug; 74(2):144-149. PubMed ID: 30728105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.
    Yang Y; Xu F; Tong J; Cai L; Jiang W; Sheng X; Pan Y; Jiang J; Zhang J; Jiang D; Zhao L; Fu G
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):389-396. PubMed ID: 30027309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
    Waks JW; Passman RS; Matos J; Reynolds M; Thosani A; Mela T; Pederson D; Glotzer TV; Zimetbaum P
    Heart Rhythm; 2018 Nov; 15(11):1601-1607. PubMed ID: 29981863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?
    Boriani G; Gerra L; Mei DA; Bonini N; Vitolo M; Proietti M; Imberti JF
    Eur J Intern Med; 2024 May; 123():37-41. PubMed ID: 38281819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices.
    DeCicco AE; Finkel JB; Greenspon AJ; Frisch DR
    Heart Rhythm; 2014 Apr; 11(4):719-24. PubMed ID: 24394157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial.
    Leef GC; Hellkamp AS; Patel MR; Becker RC; Berkowitz SD; Breithardt G; Halperin JL; Hankey GJ; Hacke W; Nessel CC; Singer DE; Fox KAA; Mahaffey KW; Piccini JP
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28615214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial high-rate episodes and stroke prevention.
    Camm AJ; Simantirakis E; Goette A; Lip GY; Vardas P; Calvert M; Chlouverakis G; Diener HC; Kirchhof P
    Europace; 2017 Feb; 19(2):169-179. PubMed ID: 28172715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial high-rate episodes: a comprehensive review.
    Simu G; Rosu R; Cismaru G; Puiu M; Gusetu G; Minciuna I; Istratoaie S; Tomoaia R; Zdrenghea D; Pop D
    Cardiovasc J Afr; 2021 Mar-Apr 23; 32(2):102-107. PubMed ID: 33496721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tactics of anticoagulant therapy in patients with cardiac implantable electronic devices and subclinical atrial fibrillation: A review].
    Razina TV; Serova MV; Andreev DA; Sazonova YS; Komarova AG
    Ter Arkh; 2023 May; 95(4):472054. PubMed ID: 38158984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden.
    Healey JS; Wong J
    Europace; 2019 Mar; 21(3):377-382. PubMed ID: 30418608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group.
    Boriani G; Healey JS; Schnabel RB; Lopes RD; Calkins H; Camm JA; Freedman B
    Int J Cardiol; 2019 Dec; 296():65-70. PubMed ID: 31327519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting Atrial Fibrillation in the Emergency Department in Patients with Cardiac Implantable Electronic Devices.
    Pugh M; Belott P; Greenwood KL; McNamee PL; Smith B; Craig TL; Mardekian J; Trocio J; Fanning D; Carda E
    J Emerg Med; 2019 Oct; 57(4):437-443. PubMed ID: 31506197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
    Ricci RP; Vaccari D; Morichelli L; Zanotto G; Calò L; D'Onofrio A; Curnis A; Pisanò EC; Nangah R; Brieda M; Calzolari V; Melissano D; Rovai N; Gargaro A
    Int J Cardiol; 2016 Sep; 219():251-6. PubMed ID: 27340918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving atrial fibrillation detection in patients with implantable cardiac devices by means of a remote monitoring and management application.
    Zoppo F; Facchin D; Molon G; Zanotto G; Catanzariti D; Rossillo A; Baccillieri MS; Menard C; Comisso J; Gentili A; Grammatico A; Bertaglia E; Proclemer A
    Pacing Clin Electrophysiol; 2014 Dec; 37(12):1610-8. PubMed ID: 25113510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.
    Cloutier JM; Khoo C; Hiebert B; Wassef A; Seifer CM
    Ther Adv Cardiovasc Dis; 2018 Apr; 12(4):113-122. PubMed ID: 29528778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future.
    AlTurki A; Marafi M; Russo V; Proietti R; Essebag V
    Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31547078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.